Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 06/26/2026 | CALL | $53.00 | 163 | +152 | +1,381.82% |
| 06/12/2026 | CALL | $45.50 | 110 | +109 | +10,900.00% |
| 06/12/2026 | CALL | $55.00 | 354 | +87 | +32.58% |
| 06/12/2026 | CALL | $45.00 | 106 | +70 | +194.44% |
| 06/26/2026 | CALL | $51.00 | 66 | +61 | +1,220.00% |
| 06/26/2026 | CALL | $59.00 | 78 | +60 | +333.33% |
| 06/12/2026 | CALL | $52.00 | 365 | -24 | -6.17% |
| 06/12/2026 | PUT | $57.00 | 0 | -24 | -100.00% |
| 06/18/2026 | PUT | $50.00 | 2,231 | -32 | -1.41% |
| 06/12/2026 | PUT | $58.00 | 7 | -33 | -82.50% |
| 06/18/2026 | CALL | $52.00 | 242 | -47 | -16.26% |
| 06/12/2026 | PUT | $60.00 | 0 | -73 | -100.00% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| ARK ETF Tr-ARK Innovation ETF | 7.14% | 5.61M | 322.69M |
| New Perspective Fund Inc | 4.51% | 3.55M | 204.09M |
| ARK ETF Tr-ARK Genomic Revolution ETF | 1.97% | 1.55M | 89.07M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 1.78% | 1.4M | 80.32M |
| Vanguard Extended Market Index Fund | 1.34% | 1.05M | 60.37M |
| Price (T.Rowe) Mid Cap Growth Fund | 1.21% | 950k | 54.61M |
| Growth Fund Of America Inc | 1.02% | 800.87k | 46.03M |
| Smallcap World Fund | 0.95% | 746.3k | 42.9M |
| iShares NASDAQ Biotechnology ETF | 0.76% | 600.21k | 34.5M |
| Fidelity Growth Company Fund | 0.75% | 589.59k | 33.89M |
CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential
06/03 12:30 pm
The Motley Fool
Read moreCRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking
06/01 12:30 pm
The Motley Fool
Read moreCRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?
05/31 12:11 pm
The Motley Fool
Read moreBetter Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?
05/25 08:35 pm
The Motley Fool
Read more1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?
05/11 04:15 pm
The Motley Fool
Read moreIs This Millionaire-Maker Biotech Stock a Buy Right Now?
05/06 03:30 am
The Motley Fool
Read moreWant to Build Real Wealth in Healthcare? These Stocks Are Worth Considering
04/30 06:10 am
The Motley Fool
Read moreWhat's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
04/30 05:10 am
The Motley Fool
Read moreShould You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?
04/30 03:10 am
The Motley Fool
Read moreS&P 500 Holds Near Highs Despite Oil Shock and Weak Breadth Data
04/27 12:09 pm
Investing.com
Read more3 Biotech Stocks That Could Benefit from the Patent Cliff
04/27 11:29 am
Investing.com
Read moreCRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy?
04/21 01:30 pm
The Motley Fool
Read more2 Billion Reasons to Love CRISPR Therapeutics Right Now
04/13 01:30 pm
The Motley Fool
Read moreThis Biotech Has a Pipeline That Could Redefine Its Entire Therapeutic Area
04/08 06:30 am
The Motley Fool
Read moreAnti-Aging Protein Research Takes a Step Forward with Cell Cloning
03/24 11:05 am
Benzinga
Read moreCRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?
03/23 01:30 pm
The Motley Fool
Read moreThis Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday
03/10 03:23 pm
The Motley Fool
Read moreForget CRISPR Therapeutics: This Gene‑Editing Player Already Boasts the Profits It Dreams Of
03/04 02:23 pm
The Motley Fool
Read moreIs CRISPR Therapeutics Stock Going to $0, or Will the Hype Pay Off?
02/20 01:30 pm
The Motley Fool
Read moreCRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows
02/20 11:22 am
Investing.com
Read moreThe Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026
02/13 04:10 pm
The Motley Fool
Read moreCRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens
02/13 02:45 pm
Benzinga
Read moreForget AI Stocks: This Biotech Could Cure What AI Can't Touch
01/29 01:28 pm
The Motley Fool
Read moreCathie Wood's Favorite Biotech Stock Is Under Pressure Amid Insider Sales And Slow Revenue Growth: Momentum Score Drops
01/27 05:33 am
Benzinga
Read moreGenome Editing Market Forecast to Reach $23.6 Billion by 2031 Registering 16.6% CAGR: Insights Into Technology and Investment Trends
01/22 05:56 am
GlobeNewswire Inc.
Read moreGene Therapy: 5 Biotech Stocks Chasing the $36B Prize
01/02 02:29 pm
Benzinga
Read more3 Supercharged Growth Stocks to Buy and Hold Into the 2030s
12/28 02:13 pm
The Motley Fool
Read moreIs CRISPR Therapeutics Stock Yesterday's News?
12/24 05:15 am
The Motley Fool
Read more3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
12/23 03:18 pm
The Motley Fool
Read more12 Days of Investing: My Top 12 Stocks to Buy Before 2026
12/15 12:10 pm
The Motley Fool
Read more2 Stocks That Could Soar by 52% and 282%, According to Wall Street
12/07 10:25 am
The Motley Fool
Read moreMeet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50%
11/30 05:10 am
The Motley Fool
Read moreThe Best Stocks to Buy With $1,000 Right Now
11/29 02:23 pm
The Motley Fool
Read moreMissed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
11/19 07:05 am
The Motley Fool
Read moreCRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial
11/11 10:50 am
Benzinga
Read moreHealthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead
10/08 10:15 am
The Motley Fool
Read moreGene Therapy Market Size to Worth USD 58.87 Billion Rising at 20% CAGR by 2034 | Towards Healthcare
10/08 10:00 am
GlobeNewswire Inc.
Read moreGot $200? 2 Healthcare Stocks to Buy and Hold Forever
10/01 05:10 am
The Motley Fool
Read moreGlobal Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
09/18 08:45 am
Benzinga
Read moreCRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025
09/09 04:00 pm
GlobeNewswire Inc.
Read moreWhy This Biotech Company Could Be a Growth Stock Powerhouse
09/04 10:15 am
The Motley Fool
Read moreGene Editing Market to Surpass USD 15.46 Billion by 2032, Fueled by Breakthroughs in CRISPR Technology and Precision Medicine – SNS Insider
09/02 06:00 am
GlobeNewswire Inc.
Read moreUp 50% in 3 Months, Is This Stock Still a Buy?
08/05 07:15 am
The Motley Fool
Read moreThe 3 Things That Matter for Vertex Pharmaceuticals Now
07/28 07:15 am
The Motley Fool
Read more3 Monster Stocks in the Making to Buy Right Now
07/21 12:07 am
The Motley Fool
Read moreBreaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
07/09 08:30 am
Benzinga
Read moreCRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline
06/26 07:00 am
GlobeNewswire Inc.
Read moreThe Best Stocks to Invest $1,000 in Right Now
06/24 04:17 am
The Motley Fool
Read more